Minovia Therapeutics and Astellas Pharma have signed a global strategic partnership and licence agreement to research, develop and market new…
30 Jul 2021
Takeda and Frazier to launch HilleVax for norovirus vaccine development
Takeda Pharmaceutical and Frazier Healthcare Partners have partnered to launch a biopharmaceutical company named HilleVax to develop and market Takeda's norovirus vaccine candidate, HIL-214 (previously TAK-214). A virus-like particle (VLP)…
29 Jul 2021
Deep Genomics raises $180m to advance drugs for genetic diseases
Deep Genomics has secured $180m in Series C funding round to advance its artificial intelligence (AI)-discovered drug programmes for genetic diseases into the clinic. The financing round was led by…
28 Jul 2021
Amgen to acquire biotech company Teneobio for up to $2.5bn
Amgen has signed an agreement to acquire a clinical-stage biotechnology company, Teneobio, for a total consideration of up to $2.5bn. Teneobio, which is privately held, focuses on the development of…
28 Jul 2021
AbbVie and Calico extend partnership on drugs for age-related diseases
AbbVie and Calico Life Sciences have expanded their partnership to discover, develop and commercialise novel treatments for age-related diseases such as neurodegeneration and cancer. The companies initially entered a research…
28 Jul 2021
Dyadic and Rubic to develop Covid-19 vaccines for African markets
Dyadic International has entered a Covid-19 vaccine technology transfer and licencing agreement with South Africa-based company, Rubic Consortium, to discover, develop, analyse and produce cost-efficient vaccines for supply mainly to…
27 Jul 2021
PerkinElmer agrees to acquire antibody maker BioLegend for $5.25bn
PerkinElmer has signed an agreement to acquire antibody and reagent maker BioLegend for nearly $5.25bn in cash and stock. PerkinElmer noted that the acquisition, which is subject to some adjustments,…
© Copyright Verdict Media Limited 2021
Powered by
